North America continues to dominate the paediatric and neonatal testing kits market, driven by high birth rates, advanced ...
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...
Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.